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Abstract
Background: The occurrence of liver cancer is higher in males than in females, and the incidence
increases during aging. Signaling pathways regulated by retinoid × receptor α (RXRα) are involved
in hepatocellular carcinogenesis. The phenotype of hepatocyte RXRα deficient mice is different
between genders. To explore the impact of hepatocyte RXRα deficiency on gender-dependent
hepatic gene expression, we compared the expression profiles of cancer-related genes in 6 and 24
month old male and female mice.
Results: In 6 month old mice, male mutant mice showed more cancer-related genes with
alteration in mRNA levels than females did (195 vs. 60). In aged mice (24 month), female mutant
mice showed greater deviation in mRNA expression levels of cancer-related genes than their male
counterparts (149 vs. 82). The genes were classified into five categories according to their role in
carcinogenesis: apoptosis, metastasis, cell growth, stress, and immune respnse. In each category,
dependent upon age and gender, the genes as well as the number of genes with altered mRNA
levels due to RXRα deficiency varies.
Conclusion: The change in hepatic cancer-related gene expression profiles due to RXRα
deficiency was gender- and age-dependent. The alteration of mRNA levels of cancer-related genes
implied that aberrant RXRα signaling could potentially increase the risk of liver cancer and that
retinoid signaling might contribute to gender- and age-associated liver cancer incidence.
Background
RXRs (Retinoid × Receptors), belonging to the nuclear
receptor superfamily, play important roles in detoxifica-
tion, apoptosis, differentiation, and proliferation through
hetero-dimerizing with other nuclear receptors [1]. RXR α,
β, and γ are the receptors for retinoids, and have been used
to prevent and treat cancer. RXRα is the most prevalent
receptor expressed in liver. Aberrant RXRα-induced path-
ways have been implicated as possible mechanisms for
the development of hepatocellular carcinoma [2,3].
Hepatocyte-specific RXRα-deficient mice were first gener-
ated by Wan etc. [4,5]. Although hepatocyte RXRα defi-
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metabolic pathways including fatty acid, cholesterol, and
xenobiotic are compromised due to hepatocyte RXRα
deficiency. Furthermore, shortened hepatocyte lifespan
and impaired capacity for liver regeneration after partial
hepatectomy are detected in hepatocytes that do not
express RXRα [6]. These findings indicate that hepatocyte
RXRα is not only important for liver metabolism, but also
in control of hepatocyte proliferation and survival.
The impact of RXRα deficiency on the expression of RXRα
target genes is gender dependent. The expression of cyto-
chrome P450 (CYP450) genes including Cyp4a, 3a, and
2b are differentially expressed in male and female hepato-
cyte RXRα-deficient mice [7]. Using sex hormone treat-
ments, we have previously shown that male hormones
might have an impact on regulating RXRα-mediated sign-
aling [7]. In addition to gender, aging also imposes signif-
icant changes on nuclear receptor-mediated gene
expression in hepatocytes [8]. Nuclear receptor signaling
pathways are in hypo-functioning status in an aged per-
son's peripheral blood mononuclear cells [9]. The inci-
dence of liver cancer is much higher in males than in
females, and increases with aging. Based on these observa-
tions, we hypothesize that aberrant hepatocyte RXRα sig-
naling might have complex repercussions on cell
biological activities and contribute to the risk of liver car-
cinogenesis in an age and gender dependent manner.
To study the impact of hepatoctye RXRα deficiency on
cancer-related gene expression in each gender, we have
performed microarray analyses using livers derived from 6
and 24 month old male and female wild type and hepato-
cyte RXRα-deficient mice. It is generally recognized that 6
month old mice are mature and 24 month old mice are
aged [10,11]. We used Ingenuity Pathway software to
identify cancer-related genes. Generally, these genes can
be classified into five categories that are associated with
carcinogenesis: 1) apoptosis; 2) stress response; 3) cell
migration; 4) cell cycle/growth regulation; and 5)
immune response. Our data demonstrated that in 6
month old mice, hepatocyte RXRα deficiency resulted in
more changes (both in number and fold) of gene expres-
sion profiles in male than in female mice; in contrast, in
aged mice (24 month old), the pattern was reversed with
females showing more changes in genetic expression pro-
files than their male counterparts. Our data provide a
database for identification of candidate genes that might
account for gender-, age-, and retinoid signaling-associ-
ated liver cancer development.
Results and discussion
In 6 month old hepatocyte RXRα deficient mice, 195
genes found in male mice livers had altered expression
patterns while 60 genes had changed expression patterns
in female mouse livers. In contrast to the matured mice, in
aged mice the number of genes that had altered expres-
sion patterns due to hepatocyte RXRα deficiency was
higher in female (149) than in male (82) mouse livers
(table 1). Our data suggest that hepatocyte RXRα defi-
ciency has a greater impact on males than females in
young mice. When mice are aged, the impact is greater in
female than in male mice.
To validate the microarray results, we selected 10 genes to
quantify mRNA levels by qRT-PCR. All qRT-PCR analyses
were performed on the same samples used for the micro-
array experiments. Table 2 summarized the fold change in
mRNA levels detected by qRT-PCR and microarray exper-
iments. Both methods detected similar trends of expres-
sion (up or down regulation) although the fold changes
may not be the same. There were only a few exceptions i.e.
FKBP5 and USP2. The difference in fold change may
reflect the sensitivity difference between the two methods.
Generally, the results from both methods were consistent.
Many biological processes can be compromised during
carcinogenesis. These processes include resistance to
apoptosis, unlimited replication potential, self-sufficient
growth signal, insensitivity to negative regulators, sus-
tained angiogenesis, and impaired tissue remodeling, all
which influence cancer cells to metastasize [12]. In addi-
tion, cell-host interactions such as immune response and
stress response pathways have been demonstrated to play
Table 1: Numbers of cancer related genes with altered mRNA levels.
Comparison 6 month old mice (KO vs. WT) 24 month old mice (KO vs. WT)
Gender male female male female
apoptosis 11 6 10 5
metastasis 22 6 9 8
stress inducible 8 2 4 2
cell growth 39 11 9 22
immune response 15 4 10 24
unclassified 100 29 42 61
total 195 60 82 149Page 2 of 13
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processes, we classified the cancer-related genes, which
changed their expression level due to hepatocyte RXRα
deficiency, into the five categories: apoptosis, migration,
cell growth regulation, stress induction, and immune
response.
Apoptosis-related genes
In the group of apoptosis-related genes, two general
trends were noted in table 3. (1) The number of genes
with varied mRNA levels was always higher in male
mutant mice than in female mutant mice. In 6 month old
mice, 11 apoptosis-associated genes had altered mRNA
levels in male mutant mice while in females; only 6 apop-
tosis genes had changed expression levels. In 24 month
old mice, 10 apoptosis-associated genes had significant
changes in mRNA levels in male mutant mice; while in
females, the number decreased to 5. (2) Most anti-apop-
tosis genes had increased mRNA levels; on the contrary,
most pro-apoptosis genes had decreased expression levels
in due to RXRα deficiency. In male mice, all 4 anti-apop-
tosis genes in 6 month old mice and 4 out of 5 anti-apop-
tosis genes in 24 month old mice had increased mRNA
levels. On the other hand, 4 out of 7 and 1 out of 1 pro-
apoptosis genes decreased in mRNA expression level,
respectively, in 6 and 24 month old male mice. The same
trend was also found in female mutant mice. A combina-
tion effect of up-regulated anti-apoptosis genes and
down-regulated pro-apoptosis genes indicated that RXRα-
deficient hepatocytes have a more resistant capacity to
apoptosis and that hepatocyte RXRα deficiency might
have a pro-survival effect.
Among the anti-apoptosis genes, FKBP5 (FK506 binding
protein 5) mRNA levels were increased by 4.26- and 2.63-
fold in 6 month old male and female mice, respectively,
due to hepatocyte RXRα-deficiency, and the data were
confirmed by real-time PCR. FKBP5 is a co-chaperone
molecular which interacts with HSP90 (Heat Shock Pro-
tein 90) [15]. Its roles include up-regulating the NF-κB
pathway and stimulating Bcl2 transcription. FKBP5 could
be up-regulated by androgen, glucocorticoids, and proges-
tin hormones [15]. There is no evidence showing that
FKBP5 is directly associated with RXRα-mediated signal-
ing. However, RXRα could negatively modulate androgen
signaling through binding androgen receptors directly
[16]. It is possible that in RXRα-deficient hepatocytes, the
androgen-mediated signaling could have enhanced acti-
vation levels compared with wild-type mice thus leading
to higher expression levels of FKBP5.
Another anti-apoptosis gene, USP2 (Ubiquitin Specific
Peptidase 2), also showed increased mRNA levels by 3.46-
and 2.17-fold in 6 month old hepatocyte RXRα deficient
male and female mice, respectively. USP2 is a de-ubiqui-
tinase protein and increases Mdm2 (mouse double
minute 2) [17] and FAS (fatty acid synthase) protein sta-
bility [18]. Since Mdm2 is responsible for p53 degrada-
tion, USP2 could negatively regulate the p53 pathway
activity through up-regulation of Mdm2. In prostate can-
cer cells, USP2 interacts with and stabilizes FAS, which is
often over-expressed in biologically aggressive human
tumors. Functional inactivation of USP2 results in
decreased FAS protein and enhanced apoptosis in prostate
cancer [18]. As with FKBP5, USP2 is also up-regulated by
androgen. The similarly elevated expression patterns for
FKBP5 and USP2 genes suggest that they are likely regu-
lated by the same mechanism, possibly up-regulation of
androgen signaling activity due to RXRα deficiency. In
addition, the qRT-PCR results showed that in both gen-
ders, the levels of FKBP5 and USP2 mRNA were not
increased in 24 month old mutant mice probably due to
decreased androgen level in aged mice.
We previously showed that hepatocyte RXRα-deficient
mice have increased serum cholesterol and triglyceride
levels [5], indicating an altered fatty acid metabolism
pathway. Our results implied elevated serum triglyceride
and cholesterol levels might in part be due to increased
activity of FAS because of up-regulation of USP2. Collec-
tively, the changed trends in apoptosis related genes
implied that RXRα-deficient hepatocytes have an
increased resistance to apoptosis.
Table 2: Validation the changes of mRNA levels in selected 
genes.
Comparison 6 month old mice
KO vs. WT
24 month old mice
KO vs. WT
Methods
Gender male female male female
FKBP5 4.26 2.63 2.81 (-) micro-array
3.26 2.23 (-) (-) qRT-PCR
USP2 3.46 2.17 3.97 (-) micro-array
3.14 2.2 (-) (-) qRT-PCR
Caspase 8 -2.04 (-) -2.31 (-) micro-array
-1.98 (-) -3.08 (-) qRT-PCR
THBS1 -7.11 (-) (-) (-) micro-array
-22.21 (-) (-) (-) qRT-PCR
SERPINE1 -23.48 (-) (-) (-) micro-array
-11.76 (-) (-) (-) qRT-PCR
FOS -5.74 (-) (-) (-) micro-array
-9.94 (-) (-) (-) qRT-PCR
ATF3 -33.85 (-) (-) (-) micro-array
-24.32 (-) (-) (-) qRT-PCR
DNAJB1 -11.30 (-) (-) (-) micro-array
-6.10 (-) (-) (-) qRT-PCR
EGR1 -15.88 (-) (-) (-) micro-array
-9.33 (-) (-) (-) qRT-PCR
BTG2 -5.26 (-) (-) (-) micro-array
-9.34 (-) (-) (-) qRT-PCR
(-): No significant change on mRNA expression level.Page 3 of 13
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Genes in this group play important roles in cell migration
and angiogenesis and are associated with metastasis, a key
feature of malignant cancer cells. Generally, the trends
observed in this group were different depending upon age
and gender (table 4).
In 6 month male RXRα-deficient mice, 22 genes showed
significant change in mRNA levels. Among those, 6 out of
6 anti-metastasis genes showed reduction of mRNA levels
because of RXRα deficiency. Other genes associated with
pro-metastasis showed either up- or down-regulation in
mRNA levels due to RXRα deficiency. In female hepato-
cyte RXRα-deficient mice, only 6 migration-related genes
showed significant changes in their mRNA level.
At 24 month of age, male and female mutant mice
showed 9 and 8 genes with alteration in their mRNA lev-
els, respectively. Thus, in aged mice, the difference in the
number of genes with deviated mRNA levels is no longer
obvious between genders; in contrast, at 6 month of age,
the numbers of genes with altered mRNA levels in male
and female mutant mice were 22 and 6, respectively.
Another striking observation was that many pro-metasta-
sis genes increased their mRNA levels in aged RXRα defi-
cient mice. In contrast, very few anti-metastasis associated
genes showed change in mRNA levels in aged mice.
In the group of anti-metastasis associated genes, the levels
of CD36, THBS1 (thrombospondin 1), and SERPINE1
(Serpin Peptidase Inhibitor) mRNA decreased by 2.16-,
7.11-, and 23.48-fold, respectively, in 6 month old male
mutant mice. Real time PCR results showed that THBS1
and SERPINE1 were down-regulated in mRNA levels by
22.21-, and 11.76-fold, respectively. THBS1 is the receptor
for CD36 and a potent angiogenesis inhibitor. Down-reg-
ulation of THBS1 has been suggested to increase tumor
growth and metastasis by modulating angiogenesis in a
variety of tumor types [19]. SERPINE1, also named PAI-1
(plasminogen activator inhibitor-1), has been used in
gene therapy for inhibition of melanoma metastasis [20].
There were also some pro-metastasis genes, such as CAV1
(caveolin 1) and FN1 (fibronectin 1), which exhibited
increased mRNA levels by 2.86- and 2.67-fold, respec-
tively, in 6 month old male mice. On the contrary, in
female hepatocyte RXRα-deficient mice, those genes,
except CD36, did not show changes in expression levels.
These observed expression patterns indicate that RXRα
deficiency had a greater impact on metastasis related gene
expression in males than in female mice at an earlier stage
Table 3: Fold changes of the mRNA levels of the apoptosis-related genes in male and female hepatocyte RXRα-deficient mouse livers.
6 month male mice (KO vs. WT) 6 month female mice (KO vs. WT)
Name Fold Change function Name Fold Change function
FKBP5 4.26 anti-apoptosis FKBP5 2.63 anti-apoptosis
USP2 3.46 anti-apoptosis USP2 2.17 anti-apoptosis
CFLAR 2.56 anti-apoptosis BCL6 2.14 anti-apoptosis
BGN 2.4 anti-apoptosis SERPINA3K 2.06 anti-apoptosis
BIK 4.41 pro-apoptosis BGN -2.12 anti-apoptosis
ACVR2B 3.55 pro-apoptosis ANP32A -2.01 pro-apoptosis
BNIP2 2.09 pro-apoptosis
CASP8 -2.04 pro-apoptosis
EMP2 -2.7 pro-apoptosis
DUSP6 -4.26 pro-apoptosis
BCL2L11 -5.61 pro-apoptosis
24 month male mice (KO vs. WT) 24 month female mice (KO vs. WT)
Name Fold Change function Name Fold Change Function
USP2 3.97 anti-apoptosis IER3 2.23 anti-apoptosis
FKBP5 2.81 anti-apoptosis BCL6 2.08 anti-apoptosis
IER3 2.8 anti-apoptosis BIK 2.22 pro-apoptosis
DUSP1 2.3 anti-apoptosis WNK1 -2.35 pro-apoptosis
BIRC4 -3.19 anti-apoptosis DIABLO -2.87 pro-apoptosis
CASP1 2.83 pro-apoptosis
UBE1L 2.36 pro-apoptosis
ZBTB16 2.19 pro-apoptosis
SOX9 -2.09 pro-apoptosis
CASP8 -2.27 pro-apoptosisPage 4 of 13
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mice might have more cell movement ability than wild
type hepatocytes.
Our data indicated that RXRα-deficient hepatocytes might
have more metastasis ability than normal hepatocytes.
Male mutant mice at 6 month of age had 22 genes with
changed their mRNA levels. All 8 anti-metastasis genes
showed decreased mRNA levels. When mice were 24
month old, the up-regulation of mRNA levels in pro-
metastasis related genes became more robust in hepato-
cyte RXRα-deficient mice. It has been revealed that RXRα
ligands could inhibit cell migration through deregulation
of matrix metalloproteinase-9 or TIMP-1 production [21].
Down-regulation of THBS1 and SERPINE1 when retinoid
signaling is compromised provide another mechanism by
which retinoids might have an anti-metastasis role. Our
data also suggest that the impact of RXRα on metastasis is
gender and age dependent.
Stress response-related genes
Several HSP (Heat Shock Protein) genes decreased their
mRNA levels due to RXRα deficiency (table 5). At 6
month of age, male and female mutant mice had 6 and 2
HSP genes with decreased mRNA levels, respectively. At
24 month of age, two HSP genes, HSPB1 (heat shock 27
kDa protein 1) and HYOU1 (hypoxia up-regulated 1),
showed decreased mRNA levels due to RXRα deficiency.
Table 4: Fold changes of the mRNA levels of the metastasis-related genes in male and female hepatocyte RXRα-deficient mouse 
livers.
6 month male mice (KO vs. WT) 6 month female mice (KO vs. WT)
Name Fold Change Function Name Fold Change function
ARHGDIB -2.05 anti-metastasis BRMS1 -2.16 anti-metastasis
KRT18 -2.15 anti-metastasis CD36 -2.88 anti-metastasis
CD36 -2.16 anti-metastasis MYO10 2.63 pro-metastasis
KRT19 -2.43 anti-metastasis ROCK1 -2.24 pro-metastasis
THBS1 -7.11 anti-metastasis CTTN -2.88 pro-metastasis
SERPINE1 -23.48 anti-metastasis ITGA6 -3.64 pro-metastasis
CAV1 2.86 pro-metastasis
FN1 2.67 pro-metastasis
ID2 2.65 pro-metastasis
DDEF1 2.52 pro-metastasis
CLCA1 2.33 pro-metastasis
S100A10 -2.09 pro-metastasis
ADAM12 -2.12 pro-metastasis
CNN2 -2.16 pro-metastasis
PLAUR -2.25 pro-metastasis
PLAT -2.30 pro-metastasis
NEDD9 -2.39 pro-metastasis
SPP1 -2.75 pro-metastasis
CTGF -2.90 pro-metastasis
VIM -3.25 pro-metastasis
LGALS7 -3.79 pro-metastasis
EPHA2 -4.71 pro-metastasis
24 month male mice (KO vs. WT) 24 month female mice (KO vs. WT)
Name Fold Change Function Name Fold Change function
TIMP4 4.07 anti-metastasis DDR1 -2.20 anti-metastasis
ANK3 2.07 anti-metastasis TFF3 11.22 pro-metastasis
LGALS3 2.00 anti-metastasis ADAM15 3.38 pro-metastasis
TFF3 4.05 pro-metastasis MMP9 2.49 pro-metastasis
CTGF 2.22 pro-metastasis ITGB1 2.48 pro-metastasis
MT1E 2.19 pro-metastasis CSF2RB 2.32 pro-metastasis
CAV1 2.15 pro-metastasis FOXM1 2.13 pro-metastasis
PLAUR 2.03 pro-metastasis MYO6 -4.70 pro-metastasis
PTP4A3 -2.55 pro-metastasisPage 5 of 13
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C. elegans to humans. HSP genes constitute the cellular
protection mechanism and can be induced by various
physical, chemical, and biological factors. In 6 month old
RXRα-deficient male mice, DNAJB1 (Dnaj homologue,
subfamily B, member 1), HSPB1, HSPA1A (Heat Shock 70
KDa Protein 1A), and HSPA1B (Heat Shock 70 KDa Pro-
tein 1B) had reduced mRNA levels by 11.30-, 10.29-,
3.86-, and 3.42-fold, respectively. This coordinated down-
regulation of the HSP family genes indicated that these
genes were regulated by common mechanisms. In 6
month old hepatocyte RXRα-deficient female mice, only 2
genes (HSPA8 and HSPB1) had reduced mRNA levels of
2.50- and 4.66-fold, respectively. Thus, hepatocyte RXRα
deficiency has a greater impact on HSP gene expression in
male than in female mice. In aged mice, there was no gen-
der difference in the expression pattern of the HSP family
genes related to RXRα deficiency. HSPB1 and HYOU1
both exhibited decreased mRNA levels in male and female
aged mutant mice to a similar extent. HSPB1 mRNA levels
were consistently decreased in both male and female
mutant mice of both age groups.
Some small HSP genes expression levels such as HSP27
can be up-regulated by RXR/RAR heterodimer in lens [22];
furthermore, RXR ligand 9-cis RA (retinoid acid) increases
the HSP gene expression in Jurkat cells [23]. Rocchi, P., et
al. suggested that the expression of HSPB1 could be up-
regulated by androgen ablation [24]. Another report
revealed that exogenous androgen treatment could delay
stress response by decreasing the expression of HSP70
[25]. Down-regulation of these HSP genes implied that
RXRα-deficient hepatocytes had a reduced protective abil-
ity and might be more susceptible to injury resulted from
external stimuli compared with wild type hepatocytes. It is
possible that there was increased androgen signaling
activity due to RXRα deficiency because RXRα is a negative
regulator for the androgen pathway, leading to inhibition
of HSP family mRNA expression. Another phenomenon
that we observed is that the number of HSP family genes
which showed alteration in mRNA levels is higher in male
than in female when mice are 6 month old. However, this
gap decreased when mice were aged. Since androgen lev-
els are higher in male than in female and decrease during
aging, the physiological changes of androgen levels may
account for this gender- and age-dependent gene expres-
sion pattern. It has been shown that RXRα-deficient hepa-
tocytes have a shortened lifespan [6]. Our data implied
down-regulation of HSP genes expression in RXRα-defi-
cient hepatocytes might result in decreased cell protection
ability and consequently render the cells prone to death.
Cell growth regulation-related genes
Retinoids could arrest cell cycle progression and induce
apoptosis in many types of cancer cells through activation
of RXRs. RXRα signaling plays critical roles in cell growth
and differentiation. In RXRα hepatocyte-deficient mice,
many genes associated with cell growth had changes in
their mRNA levels. Again, this difference in gene expres-
sion pattern is gender and age dependent (table 6).
More genes altered expression patterns in male mutant
mice compared with female mutant mice at 6 month of
age (both in numbers and fold). For example, Jun, Fos,
and Myc mRNA levels decreased by 2.87-, 5.74-, and 7.76-
fold, respectively, in male mutant mice; on the other
Table 5: Fold changes of the mRNA levels of the stress-inducible genes in male and female hepatocyte RXRα-deficient mouse livers.
6 month male mice (KO vs. WT) 6 month female mice (KO vs. WT)
Name Fold Change function Name Fold Change function
GADD45G 3.89 stress inducible HSPA8 -2.50 stress inducible
DDIT4 2.30 stress inducible HSPB1 -4.66 stress inducible
DNAJB4 -2.39 stress inducible
HSPA1B -3.42 stress inducible
HSPB1 -3.86 stress inducible
HSPA1A -10.29 stress inducible
DNAJB1 -11.30 stress inducible
ATF3 -33.85 stress inducible
24 month male (KO vs. WT) 24 month female (KO vs. WT)
Name Fold Change function Name Fold Change function
GADD45G 2.86 stress inducible HIF1A 2.50 stress inducible
DDIT4 2.18 stress inducible HIPK2 -2.22 stress inducible
HSPB1 -2.59 stress inducible HSPB1 -2.62 stress inducible
HYOU1 -2.75 stress inducible HYOU1 -3.54 stress induciblePage 6 of 13
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livers.
6 month male mice (KO vs. WT) 6 month female mice (KO vs. WT)
Name Fold Change function Name Fold Change function
LCN2 6.37 oncogene LCN2 4.57 oncogene
PIM1 4.10 oncogene GFRA1 2.15 oncogene
MAFB 4.07 oncogene PTTG1 -4 oncogene
ERBB3 2.05 oncogene PROM1 -5.61 oncogene
REL -2.34 oncogene PLAGL1 -2.09 suppressor
MDM2) -2.47 oncogene KLF6 -2.19 suppressor
JUN -2.87 oncogene WWOX -2.2 suppressor
RHOB -2.93 oncogene CAPG -2.23 suppressor
PTTG1 -2.95 oncogene KLF4 -2.32 suppressor
RHOC -3.06 oncogene GJA1 -2.91 suppressor
ROS1 -3.14 oncogene GSN -3.18 suppressor
SERTAD1 -3.7 oncogene PEG3 -5.96 suppressor
PML -3.9 oncogene TPM1 -11.95 suppressor
ETS2 -4.97 oncogene
FOS -5.74 oncogene
MYC -7.7 oncogene
SOCS3 3.85 suppressor
MAD1L1 3.73 suppressor
TCF21 2.82 suppressor
CEBPD 2.77 suppressor
SSBP2 2.27 suppressor
NDRG1 2.19 suppressor
HMGN1 2.1 suppressor
SLC22A18 2.08 suppressor
AIM1 2.05 suppressor
KSR1 2.04 suppressor
CDKN1A -2.32 suppressor
MBL2 -2.34 suppressor
GSN -2.42 suppressor
TPM1 -2.46 suppressor
PSRC1 -2.78 suppressor
GPX3 -2.8 suppressor
PERP -3.42 suppressor
MSX1 -3.5 suppressor
MBD1 -4.15 suppressor
BTG2 -5.26 suppressor
KLF6 -5.67 suppressor
EGR2 -6.03 suppressor
EGR1 -15.88 suppressor
24 month male mice (KO vs. WT) 24 month female mice (KO vs. WT)
Name Fold Change function Name Fold Change function
JUN 2.29 oncogene LIMK1 4.9 oncogene
PTTG1 2.25 oncogene ROS1 4.51 oncogene
PLK3 3.91 suppressor CCND1 4.44 oncogene
BLNK 2.13 suppressor APC 2.87 oncogene
GPX3 2.11 suppressor MAFB 2.57 oncogene
BEXL1 2.08 suppressor MYBL2 2.54 oncogene
WWOX -2.00 suppressor SH2B2 2.25 oncogene
PEG3 -2.2 suppressor PDGFB 2.23 oncogene
WISP1 -3.48 suppressor E2F3 2.08 oncogene
PERP -4.03 suppressor FLT4 2.02 oncogene
MYCL1 -2.08 oncogene
GPC1 -2.09 oncogenePage 7 of 13
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factor 6), EGR2, and EGR1 (early growth response 2 and
1) were down-regulated by 5.67-, 6.03-, and 15.88-fold,
respectively. KLF6 inhibits cell proliferation through up-
regulation of p21 expression in liver cells [26]. EGR1 and
2, early transcription factors, increase apoptosis in tumor
cells. The down-regulation of oncogenes indicated that in
RXRα-deficient hepatocytes, the cell growth activity was
compromised, providing another reason for the observed
shortened cell lifespan due to RXRα deficiency. The same
trend observed in tumor suppressor genes suggested that
negative regulation of cell cycle was also impaired. For
example, p21 is up-regulated by activation of RXR/RAR
dimer in HepG2 cells [27]. Consistently, our data showed
the decrease of p21 mRNA levels by 2.32 folds in 6 month
old male mutant mice. BTG2 (B-cell translocation gene
2), a downstream effector of the p53 pathway [28], also
had a 5.26 fold reduction. Several genes belonging to the
p53 pathway had altered mRNA levels and lead to com-
promised p53 pathway activity. The impairment of the
p53 pathway and other negative regulators implied that
due to RXRα deficiency hepatocytes would surpass the cell
cycle barrier more easily and be transformed into malig-
nant cells. In female mutant mice, the mRNA levels of the
above mentioned genes were not changed. One obvious
trend the data points to is that all negative regulator genes
for cell cycle transition decreased their mRNA levels in
female mutant mice. It also implies cell cycle checkpoint
machinery is impaired in female mutant mice.
Contrary to 6 month old female mutant mice, 24 month
old female mutant mice had more genes with modified
mRNA levels than did the male mutant mice of the same
age group (22 vs. 10). In addition, no obvious trends in
gene expression patterns were noted. Oncogenes and
tumor suppressor genes were up or down regulated ran-
domly.
The impact of RXR-mediated pathways on cell growth is
very complex. It can be tissue- or cell type-specific. The
activation of RXR/CAR, RXR/PXR, and RXR/PPARα path-
ways could induce hepatomegaly [29-31]. On the con-
trary, RXR/RAR or RXR/VDR pathways inhibit tumor cell
growth [1,32]. It is likely that the complexity of changes
seen in gene expression profiles reflect the net results of
combined proliferative and anti-proliferative effects due
to hepatocyte RXRα deficiency.
Our data implied that in matured livers, RXRα deficiency
has more impact on cell growth-related gene expression
levels in males than in females; but in aged liver, female
mice have more changes in cell growth-related gene
expression patterns than do male mice.
Immune response-related genes
Immune response-related genes also had significant
changes in mRNA level due to RXRα deficiency (table 7).
At 6 month of age, male and female mutant mice had 15
and 4 genes with modified mRNA levels, respectively;
however, at 24 month of age, there were 10 and 24 genes
with change expression levels in male and female mice,
respectively. In aged mice, the number of genes with
altered mRNA levels increased significantly in female
mutant mice. Another striking change in aged mice was
that most of the immune response-related genes (8 out of
10 in males and 18 out of 24 in females) increased in
mRNA levels. Such expression trends were not found in 6
month old mice, implying increased inflammation status
might occur in both genders at old age due to RXRα defi-
ciency.
The RXR/PPAR dimer attenuates the inflammation
response in colon [32]. RXR and PPAR agonists decrease
TNFα (tumor necrosis factor α) and IL-1β (interleukin 1β)
mRNA levels. In liver tissue, the acute response to external
stimulus was associated with a down-regulation of RXRα
expression [33]. Lipopolysaccharide (LPS) induces a
rapid, dose-dependent decrease in RXRα, β, and γ proteins
in hamster liver [33]. Alcohol induced pro-inflammation
gene expression (TNFα, IL6, and IL1β) is enhanced due to
hepatocyte RXRα deficiency [34]. These observations
implied an inverse correlation between inflammation and
RXRα signaling. These findings indicate that RXRα defi-
ciency increases inflammation response to stimulus,
which might be due to deregulation of a panel of
immune-related genes. Furthermore, the impact of RXRα
CDK5 -2.11 oncogene
DCT -2.3 oncogene
SH3RF1 -2.35 oncogene
NKX2-5 -2.42 oncogene
BANP 3.97 suppressor
PEG3 2.91 suppressor
IFI16 2.63 suppressor
BLNK -2.55 suppressor
DKK3 -4.13 suppressor
GPR65 -6.82 suppressor
Table 6: Fold changes of the mRNA levels of the cell growth-related genes in male and female hepatocyte RXRα-deficient mouse 
livers. (Continued)Page 8 of 13
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in aged than in young mice.
The impact of hepatocyte RXRα-deficiency on the 
expression of gender-dependent genes
The expression of many hepatic genes are gender depend-
ent [35]. However, the findings might vary depending
upon the age and strain of mice studied. The susceptibility
of night blindness and xerophthalmia, the most common
symptoms of vitamin A deficiency, are also gender
dependent; the incidence is higher in males than females
[36]. Thus, we studied the impact of RXRα deficiency on
the expression of hepatic cancer-related genes that have a
gender-dependent expression pattern. Our data showed
Table 8: Number of cancer-related genes that showed gender-dependent (male vs. female) expression pattern in 6- and 24-month old 
wild type and hepatocyte RXRα-deficient mice
Wild Type specific (A) RXRα deficiency specific (B) Overlap (C) Wild type total (A+C) RXRα deficiency total (B+C)
6-month 240 111 89 329 200
24-month 76 116 51 127 167
Table 7: Fold changes of the mRNA levels of the immune response genes in male and female hepatocyte RXRα-deficient mouse livers.
6 month male mice (KO vs. WT) 6 month female mice (KO vs. WT)
Name Fold Change function Name Fold Change function
DSCR1 -5.50 immune response CD9 -2.2 immune response
CXCL10 -4.47 immune response CD24 -4.2 immune response
IKBKB -3.31 immune response HLA-G -2.38 immune response
LIFR -3.25 immune response FSTL1 -2.14 immune response
IGHG1 -2.53 immune response
S100A9 -2.39 immune response 24 month female mice (KO vs. WT)
IGHM -2.17 immune response Name Fold Change function
MME -2.17 immune response B2M -2.47 immune response
FCGR2B -2.14 immune response IL7 -2.38 immune response
CXXC5 2.01 immune response IL17RD -2.28 immune response
CCL19 2.04 immune response LIFR -2.07 immune response
TAX1BP1 2.13 immune response HLA-G -2.03 immune response
SAA4 2.18 immune response NFATC2 -2.03 immune response
CXCL2 3.39 immune response CD14 2.02 immune response
HLA-G 3.76 immune response CD48 2.02 immune response
FCER1G 2.05 immune response
HLA-E 2.05 immune response
NFATC4 2.06 immune response
IL1RN 2.14 immune response
24 month male mice (KO vs. WT) IGHM 2.23 immune response
Name Fold Change function CD24 2.38 immune response
IL13RA1 -2.57 immune response S100A9 2.4 immune response
HLA-G -2.33 immune response NFE2 2.42 immune response
DSCR1 2.01 immune response IL12RB1 2.46 immune response
CCL7 2.03 immune response LIF 2.6 immune response
NTRK3 2.23 immune response IL1A 2.76 immune response
NTRK2 2.29 immune response IL16 2.83 immune response
CXCL3 2.47 immune response SLPI 2.97 immune response
CLEC2D 4.41 immune response CD55 3 immune response
CXCL10 5.92 immune response MARCO 3.24 immune response
IGH-1A 8.93 immune response MEF2C 5.03 immune responsePage 9 of 13
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old wild type and hepatocyte RXRα-deficient mice are 329
and 200, respectively. When the mice were aged, the
number of gender-dependent genes in wild type mice
dropped significantly (127), but not so much in mutant
mice (167) suggesting aging narrowed the gender gap
more in wild type mice than in the mutant mice (table 8).
There were common gender-dependent genes in both
wild type and hepatocyte RXRα-deficient mice. The names
of the genes that showed the greatest fold changes and
those genes had the greatest fold changes due to RXRα
deficiency at 6-month old age are listed (tables 9 and 10).
Also at 24-month old, those genes showed the greatest
fold change and genes had the greatest fold changes due
to hepatocyte RXRα deficiency are listed in Tables 11 and
12. Surprisingly, the gender-dependent hepatic gene
expression was also age-dependent as there was no over-
lap between the two age groups. Our data indicate that
RXRα deficiency affects gender-dependent hepatic gene
expression and that this effect is age-dependent.
Conclusion
Collectively, RXRα deficiency could lead to significant
changes in expression levels of cancer-associated genes in
a gender- and age-dependent manner. Overall, there is
increased resistance for apoptosis; increased cell migra-
tion activity; impaired cell protection ability; compro-
mised cell cycle checkpoint machinery, and elevated
inflammatory status. These changes may reflect the dereg-
ulation of multiple pathways in liver owing to RXRα defi-
ciency. Although 24 month old hepatocyte RXRα-
deficient mice do not develop spontaneous liver cancer,
our data implied that hepatocyte RXRα-deficient mice
might be more susceptible to cancer development, and
this increased risk might be gender- and age-dependent
manner.
The current study provides a database of cancer-related
hepatic genes that might contribute to a difference in liver
cancer incidence between genders as well as due to aging
or retinoid signaling deregulation. The limitation of this
study is that the role of those genes associated with liver
cancer remains to be characterized in actual liver cancer
models, which will be done in our future study.
Methods
Animals
Animal protocols were approved by the institutional ani-
mal use committee of the University of Kansas Medical
Center, Kansas City. Male and Female C57BL/6J wild type
and RXRα knock out mice were weaned at 28 days,
housed individually, given free access to water, and ran-
domly assigned to study groups. Four groups of mice were
used to determine the effects on gene expression profile at
two ages in both male and female mice. Each group had 3
mice. At particular time points after birth, 6 month
(mature) and 24 month (aged) mice were sacrificed by
cervical dislocation, and the livers were rapidly excised
Table 10: Top ten gender-dependent cancer-related genes that have the greatest fold change due to hepatocyte RXRα deficiency.
Male vs. Female (6 month old mice)
Genes in C Folds (WT) Folds (KO) Fold change due to RXRα deficiency
MYC 33.49 5.52 6.07
CDKN1A 27.04 5.03 5.38
CYP17A1 -32.26 -10.32 3.13
BTG2 10.53 3.48 3.03
HSPA1B 23.96 8.35 2.87
ABCB1 -8.77 -19.23 0.46
B4GALNT1 -2.73 -6.06 0.45
PTP4A3 -4.33 -10.67 0.41
CXCL2 2.89 8.40 0.34
HSPB1 6.40 19.48 0.33
Table 9: Ten gender-dependent genes, which have the greatest 
fold changes, in wild type and hepatocyte RXRα-deficient 6-
month old mice.
Male vs. Female in WT Male vs. Female in KO
Genes in A Folds Genes in B Folds
DNAJB1 26.62 IL1R1 31.10
AFP 22.52 SOCS3 10.63
ATF3 19.34 FMN2 8.57
SERPINE1 14.99 CXCL14 6.95
HSPA1A 10.99 CAV1 6.00
PROM1 -8.55 WEE1 -4.98
CLCA1 -9.09 ID4 -5.50
DSCR1L1 -9.17 PML -6.25
CYP2C19 -13.83 GAS1 -8.93
PEG3 -16.00 PDZRN3 -10.94Page 10 of 13
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were detected in any of the animals used.
RNA Isolation and Preparation for Microarray 
Hybridization
Total RNA was isolated from frozen mouse livers using
Trizol Reagent (Invitrogen Corporation, Carlsbad, CA)
and further purified using the RNeasy Mini Kit (Qiagen
Inc., Valencia, CA). Total RNA was quantified by UV spec-
trophotometry and its integrity and quality were assessed
on RNA 6000 Nano LabChips with the Bioanalyzer 2100
(Agilent Technologies, Palo Alto, CA). Total RNA was
reverse transcribed into cDNA using reverse transcription
kit provided by Invitrogen Company. Synthesis and puri-
fication of double-stranded cDNA were conducted as
described in the Expression Analysis Technical Manual
(Affymetrix, Santa Clara, CA). Biotin-labeled cRNA was
synthesized from the purified cDNA using the BioArray
High Yield Transcript Labeling Kit according to the manu-
facturer's specifications (ENZO Life Sciences,
Farmingdale, NY). Labeled cRNA was purified using the
GeneChip Sample Cleanup Module, quantified by UV
spectrophotometry and assessed for quality with the Bio-
analyzer 2100. Twenty μg purified cRNA was fragmented
and 15 μg fragmented cRNA was hybridized to Affymetrix
Mouse Genome 430A 2.0 Array GeneChips (Affymetrix,
Santa Clara, CA) according to the Expression Analysis
Technical Manual. Washing and staining of the hybrid-
ized arrays were carried out using the Fluidics Station 400
and arrays were subsequently scanned with the Hewlett
Packard GeneArray Scanner.
Microarray Data Analysis
Affymetrix scan data (.cel files) were imported into
Rosetta Resolver for analysis (Rosetta Biosoftware, Seattle,
WA). Following intrachip normalization and background
correction, individual replicates were combined into sin-
gle "ratio experiments" by an error-weighted method
using the control group as a baseline. An agglomerative
hierarchical clustering algorithm utilizing an error-
weighted Euclidian distance measure was performed on
the ratio experiments to identify active genes. Transcripts
were defined as active if they increased or decreased by
greater than 2.0-fold. The microarray data from this work
was submitted to the ArrayExpress database and the acces-
sion number is E-MEXP-1711.
Confirmation of mRNA level changes by quantitative real-
time PCR
The synthesized cDNA was diluted 20 fold by water. All
primers and probes were designed based on nucleotide
sequences in Genbank using the Primer Express software
(PE Applied Biosystems). PCR reaction efficiency was cal-
culated for each primer pair using with five dilution
points of the calibrator sample to validate primers and
probes. The PCR product covered at least two exons
according to introns-exons organisation of selected genes.
Table 12: Top ten gender-dependent cancer-related genes that have the greatest fold change due to hepatocyte RXRα deficiency.
Male vs. Female
Genes in C Folds (WT) Folds (KO) Fold change due to RXRα deficiency
SERPINB1 -9.62 -2.41 3.99
CYP3A4 -43.86 -11.68 3.75
PROM1 -6.14 -3.13 1.96
CD74 -3.86 -2.02 1.91
OSGIN1 4.45 2.34 1.91
CAV1 2.14 3.74 0.57
IGHM -2.28 -5.68 0.40
S100A8 -6.80 -21.10 0.32
MT1E -2.03 -6.62 0.31
S100A9 -6.10 -31.35 0.19
Table 11: Ten gender-dependent genes, which have the greatest 
fold changes, in wild type and hepatocyte RXRα-deficient 24-
month old mice.
Male vs. Female in WT Male vs. Female in KO
Genes in A Folds Genes in B Folds
SNCA 6.22 CLEC2D 45.07
SOX9 4.86 ASNS 27.09
CYP26A1 4.70 RB1CC1 11.82
ABCG2 4.01 FMN2 9.39
BCL6 3.46 RAMP2 4.13
PRLR -3.98 ITGA6 -5.78
CXCL10 -5.29 DCT -6.10
CD79B -7.09 PSCDBP -6.33
IL7 -9.71 PLA2G7 -6.45
DSCR1L1 -10.94 CD55 -13.57Page 11 of 13
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Mix (PE Applied Biosystems), 0.5 μM forward and reverse
primers and 1 uM corresponding probe. Final volume is
20 μl. Reactions were carried out on ABI PRISM 7900 real
time PCR system (PE Applied Biosystems) for 40 cycles
(95°C for 15 s, 60°C for 1 min). The expression fold
change for each gene was calculated using the Ct method
and β-actin was used as an internal control.
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